查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030271

生醫材料市場－全球產業規模、佔有率、趨勢、機會、預測：按材料類型、應用、地區和競爭格局分類，2021-2031年

Biomaterials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物材料市場預計將從 2025 年的 2,380.3 億美元成長到 2031 年的 6,197.2 億美元，複合年成長率為 17.29%。

這些材料由天然或合成物質組成，旨在與生物系統相互作用，用於再生、診斷或治療目的。該領域的發展主要受全球人口老化、需要先進醫療手段的慢性疾病日益普遍以及再生醫學和醫療設備技術的不斷進步所驅動。

市場概覽
預測期 2027-2031
市場規模：2025年 2380.3億美元
市場規模：2031年 6197.2億美元
複合年成長率：2026-2031年 17.29%
成長最快的細分市場 聚合物生物材料
最大的市場 北美洲

根據美國醫療器材促進協會（AdvaMed）的報告，全球醫療科技產業（該產業在產品製造中高度依賴生物材料）預計到2024年市場規模將達到約6,000億美元，顯示市場發展勢頭良好。這種穩定成長凸顯了生物材料在提高醫療效果和改善患者預後方面發揮的關鍵作用。然而，該行業在應對複雜且不斷變化的監管法規方面面臨著許多挑戰，而且基於生物材料的新產品的研發和核准所需時間也往往越來越長。

市場促進因素

全球慢性病發生率的上升和人口老化是生醫材料產業的主要驅動力，也因此對先進醫療技術的需求持續成長。隨著預期壽命的延長，人們面臨著糖尿病、整形外科疾病和心血管疾病等與老齡化相關的疾病的風險，這些疾病通常需要長期照護、手術或植入。生物材料在創傷護理產品、人工關節、心血管支架和義肢領域的研發中發揮著至關重要的作用，這些產品能夠改善患者的功能獨立性和整體生活品質。為了佐證這項需求，國際糖尿病聯盟（IDF）發布的《糖尿病地圖集》（2025版）預測，到2024年，全球20至79歲的成年人中將有約5.89億人患有糖尿病，這將加速對專用傷口敷料和血糖值監測儀等解決方案的需求。因此，這些人口結構的變化正迫使醫療保健網路提供永續且創新的醫療干預措施。

製造技術和生物材料技術的進步使得性能、功能和生物相容性更佳的先進醫療設備得以生產，顯著推動了市場成長。 3D列印、奈米技術和智慧生物材料的突破性進展，使得精密藥物傳遞機制和個人化植入的製造成為可能，有效應對了尚未解決的醫學難題。這些進步正在加速生物材料在組織工程和再生醫學等複雜領域的應用，重點在於修復功能障礙的器官和組織。大量的研發資金對於此類研發至關重要。正如美國醫療器材協會（AdvaMed）2025年10月發布的最新報告所述，美國領先的醫療設備公司在2024年全年總合投入了226億美元用於研發。尤其值得注意的是，國際糖尿病聯盟（IDF）發布的《糖尿病地圖集》（2025）指出，2024年全球與糖尿病相關的醫療保健支出首次突破1兆美元，因此，在高度依賴生物材料的眾多醫療領域，持續創新仍然至關重要。

市場挑戰

複雜且不斷變化的法規環境對生物材料產業構成重大挑戰。例如，歐盟的體外診斷醫療設備法規 (IVDR) 和醫療設備法規 (MDR) 等框架，常常延長創新生物材料產品的研發和核准流程。這些法規要求提供詳盡的文件和大量的臨床證據，在產品進入市場階段造成不確定性，最終導致製造商面臨延誤和營運困難。

應對這些嚴格的法規直接導致營運成本大幅增加，立即阻礙了市場擴張。根據歐洲醫療技術協會 (MedTech Europe) 2024 年的一項調查，歐盟體外診斷醫療器材法規 (IVDR) 和醫療器材法規 (MDR) 下的維護和認證成本較先前的指南上漲了 100% 以上。此類成本增加對研發的關鍵資金造成了壓力，從而限制了尖端生物材料產品的市場推廣。這導致生物材料上市時間延長，限制了新技術惠及患者，也阻礙了國際生物材料產業的整體發展。

市場趨勢

產業內一個顯著的趨勢是，在日益嚴格的環境法規和全球醫療保健領域向循環經濟理念轉型的推動下，可生物分解和永續材料的使用量不斷增加。這項轉型需要開發和應用生物材料，以減少其從原料採購到最終處置的整個生命週期內的環境影響。聚合物研究的進步使得開發具有客製化機械性能和分解速率的新型生物基複合材料和聚合物成為可能，這些材料可用於各種醫療應用，包括環保包裝、臨時植入和可吸收縫合線。這些創新透過減少廢棄物和避免再次手術取出植入來改善患者的治療效果。為了體現這一轉變，贏創於2026年3月發布的《2025年永續發展報告》指出，對包括永續生醫材料在內的「下一代解決方案」的投資占公司2025年總資本支出的38%。

利用積層製造技術為每位病患打造個人化醫療設備是另一項突破性趨勢，它從根本上改變了醫療設備的研發和製造方式。這種廣為人知的3D列印技術，使製造商能夠生產高度個人化的手術導板、義肢和植入，完美貼合每位患者獨特的生理結構。透過建構複雜的形狀和內部晶格結構，可以提高與生物系統的親和性，增強患者的舒適度和功能性，並縮短癒合時間。此外，這種精密製造技術能夠根據需要快速原型製作和進行大量生產，從而最佳化供應鏈，加速個人化醫療的普及。順應這一發展勢頭，Axial3D於2024年12月宣布已資金籌措，用於在全球擴展其人工智慧驅動的3D列印和醫學成像平台。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球生醫材料市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依材料種類（金屬生物材料、聚合物生物材料、陶瓷、天然生物材料）
    • 依應用領域（循環系統、整形外科、眼科、牙科等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美生醫材料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生醫材料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區生醫材料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲生醫材料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲生醫材料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球生醫材料市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • BASF SE
  • Covestro AG
  • Celanese Corporation
  • Evonik Industries AG
  • Corbion NV
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Johnson & Johnson Services Inc.
  • Medtronic plc
  • CoorsTek Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 4633

The Global market for biomaterials is anticipated to expand from USD 238.03 billion in 2025 to USD 619.72 billion by 2031, reflecting a compound annual growth rate of 17.29%. These materials consist of engineered natural or synthetic substances created to interface with biological systems for regenerative, diagnostic, or therapeutic purposes. Growth in this sector is primarily fueled by a worldwide increase in the aging population, a growing prevalence of chronic conditions requiring sophisticated medical treatments, and ongoing progress in regenerative medicine and medical device technologies.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 238.03 Billion
Market Size 2031USD 619.72 Billion
CAGR 2026-203117.29%
Fastest Growing SegmentPolymeric Biomaterials
Largest MarketNorth America

AdvaMed reports that the worldwide medical technology sector, which heavily depends on biomaterials for creating products, reached a valuation of roughly $600 billion in 2024, indicating strong market health. This steady growth highlights the vital function biomaterials serve in enhancing medical effectiveness and patient results. Nevertheless, the industry encounters major hurdles when dealing with intricate and constantly changing regulatory rules, which frequently prolong the time required to develop and approve new products based on biomaterials.

Market Driver

The escalating rates of chronic illnesses and an aging population worldwide serve as the main catalysts for the biomaterials industry, establishing a continuous need for sophisticated medical treatments. With longer lifespans, people face higher risks of age-associated ailments like diabetes, orthopedic disorders, and cardiovascular conditions, which frequently necessitate long-term care, surgical operations, or implants. Biomaterials play a vital role in creating wound care items, joint replacements, cardiovascular stents, and prosthetics that enhance functional autonomy and overall life quality. Highlighting this demand, the International Diabetes Federation (IDF) Diabetes Atlas (2025) reported that around 589 million adults between 20 and 79 years old had diabetes globally in 2024, accelerating the requirement for solutions such as specialized wound dressings and glucose monitors. Consequently, these shifting demographics are forcing healthcare networks to deliver lasting and inventive medical interventions.

Progress in manufacturing techniques and biomaterial technologies heavily drives market growth by allowing the creation of modern medical devices with improved performance, functionality, and biocompatibility. Breakthroughs in 3D printing, nanotechnology, and smart biomaterials enable the production of advanced drug delivery mechanisms and personalized implants, effectively targeting unresolved medical challenges. Such developments promote the use of biomaterials in intricate fields like tissue engineering and regenerative medicine, focusing on the restoration of compromised organs and tissues. These R&D endeavors demand major financial backing; as noted in an October 2025 update by AdvaMed, major American medical device corporations invested a minimum of $22.6 billion collectively in R&D throughout 2024. Ongoing innovation remains indispensable to the wider healthcare field, heavily reliant on biomaterials, especially considering the IDF Diabetes Atlas (2025) noted that worldwide healthcare spending related to diabetes exceeded one trillion US dollars for the first time in 2024.

Market Challenge

Intricate and constantly changing regulatory environments pose a major obstacle to the biomaterials industry. Frameworks like the European Union's In Vitro Diagnostic Regulation (IVDR) and Medical Devices Regulation (MDR) frequently cause prolonged timelines for the development and authorization of innovative biomaterial products. Because these regulations demand thorough documentation and extensive clinical proof, they create uncertainty during the market entry phase, ultimately causing setbacks and heightened operational difficulties for producing companies.

Navigating these strict rules directly results in a massive increase in operating costs, which immediately restricts market expansion. Based on results from a 2024 survey by MedTech Europe, the expenses associated with maintenance and certification under the EU IVDR and MDR have surged by 100% or more when contrasted with older guidelines. Such rising costs redirect essential funding away from R&D initiatives, thereby limiting the rollout of cutting-edge biomaterial products. As a result, the timeline for bringing biomaterials to market is delayed, restricting the availability of novel technologies to patients and hindering the broader growth of the international biomaterials sector.

Market Trends

A prominent trend in the industry is the rising use of biodegradable and sustainable materials, spurred by stricter environmental laws and a worldwide movement toward circular economy concepts within healthcare. This transition requires the creation and incorporation of biomaterials that lessen environmental harm across their entire lifespan, spanning from initial sourcing to final disposal. Advancements in polymer research allow for the production of novel bio-based composites and polymers featuring customized mechanical traits and degradation speeds tailored for various medical uses, such as environmentally friendly packaging, temporary implants, and absorbable sutures. These innovations decrease waste and enhance patient results by removing the necessity for subsequent surgeries to extract implants. Highlighting this shift, Evonik's Sustainability Report 2025, released in March 2026, noted that funding for Next Generation Solutions, encompassing sustainable biomaterials, made up 38 percent of the firm's overall capital spending in 2025.

The utilization of additive manufacturing to create patient-tailored devices is an additional game-changing trend, completely changing the design and manufacturing of medical treatments. Widely recognized as 3D printing, this method allows producers to build exceptionally personalized surgical guides, prosthetics, and implants that perfectly align with a patient's unique physical structure. Crafting complicated shapes and internal lattice frameworks promotes better assimilation with the body's biological systems, improving user comfort and functionality while shortening healing periods. Furthermore, this exact production technique enables swift prototyping and manufacturing as needed, which optimizes supply networks and speeds up the provision of customized medical attention. Reflecting this momentum, a December 2024 announcement from Axial3D revealed that the medtech company obtained USD 18.2 million in funding to expand its AI-driven 3D printing and medical imaging platform on a global scale.

Key Market Players

  • BASF SE
  • Covestro AG
  • Celanese Corporation
  • Evonik Industries AG
  • Corbion N.V.
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Johnson & Johnson Services Inc.
  • Medtronic plc
  • CoorsTek Inc.

Report Scope

In this report, the Global Biomaterials Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biomaterials Market, By Material Type

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramics
  • Natural Biomaterials

Biomaterials Market, By Application

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Others

Biomaterials Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biomaterials Market.

Available Customizations:

Global Biomaterials Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biomaterials Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Material Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramics, Natural Biomaterials)
    • 5.2.2. By Application (Cardiovascular, Orthopedic, Ophthalmology, Dental, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Biomaterials Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Material Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biomaterials Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Material Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Biomaterials Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Material Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Biomaterials Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Material Type
        • 6.3.3.2.2. By Application

7. Europe Biomaterials Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Material Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biomaterials Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Material Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Biomaterials Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Material Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Biomaterials Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Material Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Biomaterials Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Material Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Biomaterials Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Material Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Biomaterials Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Material Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Biomaterials Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Material Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Biomaterials Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Material Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Biomaterials Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Material Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Biomaterials Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Material Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Biomaterials Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Material Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Biomaterials Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Material Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Biomaterials Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Material Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Biomaterials Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Material Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Biomaterials Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Material Type
        • 9.3.3.2.2. By Application

10. South America Biomaterials Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Material Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biomaterials Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Material Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Biomaterials Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Material Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Biomaterials Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Material Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Biomaterials Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. BASF SE
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Covestro AG
  • 15.3. Celanese Corporation
  • 15.4. Evonik Industries AG
  • 15.5. Corbion N.V.
  • 15.6. Zimmer Biomet Holdings, Inc.
  • 15.7. Stryker Corporation
  • 15.8. Johnson & Johnson Services Inc.
  • 15.9. Medtronic plc
  • 15.10. CoorsTek Inc.

16. Strategic Recommendations

17. About Us & Disclaimer